← Human Trials & Peer-Reviewed Studies
Effects of zinc supplementation on superoxide dismutase activity and gene expression, and metabolic parameters in overweight type 2 diabetes patients: A randomized, double-blind, controlled trial.
Plain-language guide to PMID 31129183 (2019): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 31129183
- Journal
- Clinical biochemistry
- Year
- 2019
- Study type
- Randomized Controlled Trial
- Authors
- Nazem MR et al. (4 authors)
- DOI
- 10.1016/j.clinbiochem.2019.05.008
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
Despite the current guidelines for the management of type 2 diabetes mellitus (T2DM), patients still struggle with the hyperglycemia consequences.
Imbalance in zinc homeostasis, in particular, renders diabetic patients more susceptible to the damages of oxidative stress.
This study aimed to evaluate the effects of zinc supplementation on the superoxide dismutase gene expression and enzyme activity in overweight individuals with T2DM.
Who Took Part
By PubMed's age tags, the people studied were adults, middle-aged adults and older adults, both men and women.
In this randomized, double-blind, placebo-controlled trial, 70 overweight (BMI > 25) T2DM patients were selected based on the inclusion criteria.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
Blood samples were collected from all the individuals in the zinc group and controls for analysis.
What Was Measured
Topics PubMed links to this paper include Biomarkers, Blood Glucose, Diabetes Mellitus, Type 2, Lipids, Overweight, RNA, Messenger and Superoxide Dismutase.
The authors tagged it with the keywords Antioxidant therapy, Type 2 diabetes mellitus and Zinc supplementation.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 3 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2019 (Clinical biochemistry), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.